Join the 'Oraltag' group to help and get support from people like you.
FDA Medwatch Alert: Iodine-containing Contrast Agents for Medical Imaging: Drug Safety Communication - Rare Cases of Underactive Thyroid in Infants
Posted 17 Nov 2015 by Drugs.com
ISSUE: FDA is advising that rare cases of underactive thyroid have been reported in infants following the use of contrast media containing iodine, also called “contrast dye,” for X-rays and other medical imaging procedures. In all of the reported cases, the infants were either premature or had other serious underlying medical conditions. Available evidence leads FDA to believe that this rare occurrence is usually temporary and resolves without treatment or any lasting effects. See the Drug Safety Communication for a data summary and a list of approved Approved Iodinated Contrast Media Products. FDA approved changes to the labels of all iodinated contrast media (ICM) products to include information about these cases. No changes to current prescribing, administration, or monitoring practices are recommended. FDA will continue to evaluate this issue and will update the public when there is ... Read more
Related support groups: Diagnosis and Investigation, Iohexol, Optiray 320, Iopamidol, Omnipaque 350, Isovue-370, Conray, Omnipaque 240, Visipaque, Ioversol, Cysto-Conray, Gastrografin, Hypaque, MD-Gastroview, Cysto-Conray II, Optiray 300, Urografin 150, Oraltag, Cystografin-Dilute, Isovue-M-300